Abstract
This is a report of microvascular changes seen on fluorescein angiography (FA) and optical coherence tomography angiography (OCTA) in a 47-year-old man with macular telangiectasia Type 1 (MacTel1) after a 7-year bevacizumab (Avastin; Genentech, South San Francisco, CA) treatment course. OCTA allowed for clear visualization of most telangiectasias and aneurysms in the deep capillary plexus, with only few microvascular dilatations in the superficial plexus. In addition, areas of capillary dropout in the superficial and deep vascular plexa located near telangiectasias were documented on OCTA. Serial FA demonstrated reduced number of aneurysms and telangiectasias at the 7-year mark compared to baseline.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 263-266 |
| Number of pages | 4 |
| Journal | Ophthalmic Surgery Lasers and Imaging Retina |
| Volume | 48 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1 2017 |
Fingerprint
ASJC Scopus subject areas
- Surgery
- Ophthalmology
Cite this
Fluorescein angiography versus optical coherence tomography angiography in macular telangiectasia type i treated with bevacizumab therapy. / Yannuzzi, Nicolas A.; Gregori, Ninel; Roisman, Luiz; Gupta, Nisha; Goldhagen, Brian; Goldhardt, Raquel.
In: Ophthalmic Surgery Lasers and Imaging Retina, Vol. 48, No. 3, 01.03.2017, p. 263-266.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Fluorescein angiography versus optical coherence tomography angiography in macular telangiectasia type i treated with bevacizumab therapy
AU - Yannuzzi, Nicolas A.
AU - Gregori, Ninel
AU - Roisman, Luiz
AU - Gupta, Nisha
AU - Goldhagen, Brian
AU - Goldhardt, Raquel
PY - 2017/3/1
Y1 - 2017/3/1
N2 - This is a report of microvascular changes seen on fluorescein angiography (FA) and optical coherence tomography angiography (OCTA) in a 47-year-old man with macular telangiectasia Type 1 (MacTel1) after a 7-year bevacizumab (Avastin; Genentech, South San Francisco, CA) treatment course. OCTA allowed for clear visualization of most telangiectasias and aneurysms in the deep capillary plexus, with only few microvascular dilatations in the superficial plexus. In addition, areas of capillary dropout in the superficial and deep vascular plexa located near telangiectasias were documented on OCTA. Serial FA demonstrated reduced number of aneurysms and telangiectasias at the 7-year mark compared to baseline.
AB - This is a report of microvascular changes seen on fluorescein angiography (FA) and optical coherence tomography angiography (OCTA) in a 47-year-old man with macular telangiectasia Type 1 (MacTel1) after a 7-year bevacizumab (Avastin; Genentech, South San Francisco, CA) treatment course. OCTA allowed for clear visualization of most telangiectasias and aneurysms in the deep capillary plexus, with only few microvascular dilatations in the superficial plexus. In addition, areas of capillary dropout in the superficial and deep vascular plexa located near telangiectasias were documented on OCTA. Serial FA demonstrated reduced number of aneurysms and telangiectasias at the 7-year mark compared to baseline.
UR - http://www.scopus.com/inward/record.url?scp=85016953602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016953602&partnerID=8YFLogxK
U2 - 10.3928/23258160-20170301-12
DO - 10.3928/23258160-20170301-12
M3 - Article
C2 - 28297041
AN - SCOPUS:85016953602
VL - 48
SP - 263
EP - 266
JO - Ophthalmic Surgery Lasers and Imaging Retina
JF - Ophthalmic Surgery Lasers and Imaging Retina
SN - 2325-8160
IS - 3
ER -